Surrozen Share Price

Surrozen Share Price

NASDAQ: SRZN | Micro Cap | Healthcare
$28.42
-$2.07 (-6.79%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Surrozen Stock Performance

Open
$29.36
Prev. Close
$30.49
Circuit Range
N/A
Day Range
$28.37 - $29.87
Year Range
$13.10 - $37.23
Volume
7,724
Average Traded
$29.00

Surrozen Share Price Today

As of 21 November 2026, Surrozen, Inc.'s share price is $28.42. The stock opened at $29.36, compared to its previous close of $30.49. During today's trading session, Surrozen, Inc.'s share price traded between $28.37 and $29.87, with an average price of $29.12. Over the past 52 weeks, the stock has recorded a high of $37.23 and a low of $13.10. In terms of performance, Surrozen, Inc.'s share price has risen by 8.85% over the last six months and is up 71.46% on a year-on-year basis.

Surrozen Share Price Chart

Line chart of the Surrozen price trend over the selected period. The price fell overall, ranging from 28.37 to 30.52, ending at 28.42.
$28.37$29.87
L
Show Current Price
H

Surrozen Stock Fundamentals & Key Indicators

Market Cap
$212524.76
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-21.42
Revenue (TTM)
$3.48B
Return On Equity (TTM)
121.67%
Profit Margin
-6954.89%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
29.18%

Surrozen Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.53$5.00$5.00$0.00
Net Profit-$183.16-$127.51$32.04-$129.72
Net Profit Margin-34558.49%-2550.20%640.80%N/A
Income ChangeN/A30.38%125.13%-504.87%

Surrozen Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$12.50$0.00$10.66$3.48
Net Profit-$36.00-$43.04-$63.56-$242.03
Net Profit Margin-288.00%N/A-596.25%-6954.89%
Income ChangeN/A-19.56%-47.68%-280.79%

Surrozen Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets7.179.544.958.13
Current Assets91.5638.9341.1381.31
Total Assets98.7348.4746.0889.44
Non Current Liabilities276.5662.531.03.7
Current Liabilities9.937.327.159.73
Total Liabilities286.4969.858.1513.43
Shareholders' Equity-187.76-21.3837.9476.0

Surrozen Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-30.24-17.63-40.36-44.15
Investing-0.13-0.0351.7238.31
Financing85.0516.180.28-2.57

Corporate Actions

Split
Ex-date: 14 Dec 2023

About Surrozen

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Surrozen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$29.86
$28.37
-2.21%
Oct 2026
$31.64
$29.01
-9.17%
Sep 2026
$22.16
$31.94
+32.86%
Aug 2026
$21.48
$24.04
+7.47%
Jul 2026
$24.97
$22.37
-13.70%
Jun 2026
$24.95
$25.92
-0.73%
May 2026
$34.02
$26.11
-21.43%
Apr 2026
$29.25
$33.23
+14.07%
Mar 2026
$28.00
$29.13
+4.94%
Feb 2026
$21.37
$27.76
+28.76%
Jan 2026
$23.01
$21.56
-3.71%
Dec 2025
$16.10
$22.39
+35.08%

Surrozen Share Price FAQs